Toxicity of nucleoside-analogue reverse-transcriptase inhibitors.
Walker
U A
UA
Setzer
B
B
Volksbeck
S I
SI
D004579:Electron Transport / Q000187:drug effects; D005260:Female; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors*; D006679:HIV Seropositivity / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D008060:Lipodystrophy / Q000139:chemically induced*; D008928:Mitochondria / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase